Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

LONDON, September 19 /PRNewswire/ --

The spate of ATM withdrawals on customer accounts with fraudulent cards has sparked widespread concern across the Middle East. The incidents that happened in UAE have rattled many banks and have instilled fear in the minds of cardholders.

Dubai is maturing into a major leisure and business destination and this means that many foreign-issued cards will be used at local ATM machines. Middle East-issued cards also have a very high level of out of country spending since a large portion of cardholders are expatriates.

REYKJAVIK, Iceland, September 19 /PRNewswire/ -- More than 200 participants from 72 companies assembled at the exclusive annual international platform for sustainable energy solutions at Hilton Nordica Reykjavík September 18 and 19.

"In the next five years or so we have to lay the fundamental groundwork of a comprehensive transformation of our traffic system, our transport, how we use the roads, how we move from one place to another, whether it is a household or a city or a country." said Ólafur Ragnar Grímsson, President of Iceland, in his opening address at Driving Sustainability at Hilton Reykjavik Thursday.

TORONTO, Canada, September 19 /PRNewswire/ -- Addax Petroleum Corporation (TSX: AXC and LSE: AXC) ("Addax Petroleum" or the "Corporation") will host a management presentation to financial analysts and investors on Wednesday, September 24, 2008 in London, U.K. The Corporation's senior management team, including Mr. Jean Claude Gandur, President and Chief Executive Officer, Mr. James Pearce, Chief Operating Officer, Mr. Michael Ebsary, Chief Financial Officer, and Mr. Jeff Schrull, General Manager Exploration, will discuss the Corporation's most recent operating results and expectations regarding future operations.

LONDON, September 19 /PRNewswire/ -- Integer, a leading business consultancy in the area of global emissions regulations, today announced its latest speaker lineup for the Diesel Exhaust Fluid Forum (DEFF '08) to be held in San Diego, California, on November 11-12. The aim of this independent forum is to give exclusive insight into the commercial opportunities and concerns created by stricter heavy duty diesel vehicle emissions regulations from January 2010.

NEW YORK, September 19 /PRNewswire/ -- What: GoldenSource Corporation, a leading provider of enterprise data management (EDM) solutions, is actively participating in presentations at the Financial Technology Congress 2008. During a panel discussion, Neil Edelstein, vice president of product solutions, will discuss best practices for data integration within an organization. Attendees can visit the GoldenSource booth in the exhibition hall to talk one-on-one with Neil and other GoldenSource representatives.

Where: Financial Technology Conference 2008, The Four Seasons Hotel, Boston, MA

PHOENIX and BRITISH COLUMBIA, Canada, September 19 /PRNewswire/ --

- Focusing on Development of Treatments For Women with Endometriosis -

St. Joseph's Hospital and Medical Center, part of Catholic Healthcare West, one of the largest healthcare systems in the West with 42 hospitals in Arizona, California and Nevada and InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announces a collaborative partnership focusing on the development of treatments for women with endometriosis.